Canada Life’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67K | Sell |
7,182
-13,480
| -65% | -$126K | ﹤0.01% | 1811 |
|
|
2025
Q1 | $254K | Hold |
20,662
| – | – | ﹤0.01% | 1704 |
|
|
2024
Q4 | $273K | Hold |
20,662
| – | – | ﹤0.01% | 1721 |
|
|
2024
Q3 | $398K | Hold |
20,662
| – | – | ﹤0.01% | 1719 |
|
|
2024
Q2 | $424K | Buy |
20,662
+13,480
| +188% | +$277K | ﹤0.01% | 1711 |
|
|
2024
Q1 | $171K | Buy |
7,182
+1,587
| +28% | +$37.8K | ﹤0.01% | 1856 |
|
|
2023
Q4 | $120K | Hold |
5,595
| – | – | ﹤0.01% | 1908 |
|
|
2023
Q3 | $81K | Buy |
5,595
+2,962
| +112% | +$42.9K | ﹤0.01% | 2009 |
|
|
2023
Q2 | $55K | Hold |
2,633
| – | – | ﹤0.01% | 1996 |
|
|
2023
Q1 | $56K | Hold |
2,633
| – | – | ﹤0.01% | 2054 |
|
|
2022
Q4 | $67K | Buy |
2,633
+813
| +45% | +$20.7K | ﹤0.01% | 2042 |
|
|
2022
Q3 | $44K | Hold |
1,820
| – | – | ﹤0.01% | 2121 |
|
|
2022
Q2 | $35K | Hold |
1,820
| – | – | ﹤0.01% | 2132 |
|
|
2022
Q1 | $34K | Hold |
1,820
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q4 | $40K | Hold |
1,820
| – | – | ﹤0.01% | 2233 |
|
|
2021
Q3 | $35K | Hold |
1,820
| – | – | ﹤0.01% | 2327 |
|
|
2021
Q2 | $31K | Hold |
1,820
| – | – | ﹤0.01% | 2401 |
|
|
2021
Q1 | $40K | Hold |
1,820
| – | – | ﹤0.01% | 2359 |
|
|
2020
Q4 | $40K | Buy |
+1,820
| New | +$40K | ﹤0.01% | 2361 |
|